Last reviewed · How we verify
NCT03944187
Sonographic Assessment for Prediction of Labor Induction Success
trial testing Transvaginal sonography in Induction of Labor Affected Fetus / Newborn in 200 participants. Completed in 1 April 2022.
31 December 2021
Quick facts
| Lead sponsor | Rambam Health Care Campus |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 June 2019 |
| Primary completion | 31 December 2021 |
| Estimated completion | 1 April 2022 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Transvaginal sonography
Conditions studied
- Induction of Labor Affected Fetus / Newborn — all drugs for Induction of Labor Affected Fetus / Newborn →
Sponsor
Rambam Health Care Campus — full company profile →
Who can join
Adults 18 to 45, female only, with Induction of Labor Affected Fetus / Newborn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is conducted to assess several sonographic parameters for prediction of labor induction success. These parameters include cervical length, fetal head circumference, and fetal head to cervix angle.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03944187
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transvaginal sonography
Trials testing the same drug.
- NCT03948932 — Cervix Uteri "Resistance" Measurements · unknown
- NCT03935607 — The Added Contribution of Transvaginal Sonographic Evaluation of Amniotic Fluid Index · completed
- NCT03859258 — Ultrasound Based Study For Niche Development In The Uterine Cesarean Section Scar · completed
Other recruiting trials for Induction of Labor Affected Fetus / Newborn
Currently open trials in the same condition.
- NCT06375746 — The Impact of a Customized Informative Video Prior to Induction of Labor on Anxiety Relieve. · NA · recruiting
- NCT06325007 — Castor Oil Ingestion and Balloon Catheter for Labor Induction in Nulliparous · NA · recruiting
- NCT06187779 — Induction ATAD Catheter and Lower Segment Thickness · NA · active not recruiting
- NCT05759988 — Cervical Ripening as an Outpatient Method Using the Foley (COMFORT) · NA · recruiting
Other Rambam Health Care Campus trials
Trials by the same sponsor.
- NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
- NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
- NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
- NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
- NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03944187 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
- Last refreshed: 20 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03944187.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing